ECL vs TOVX · P/E 35, rev $8.48B vs rev $300.0K
Ecolab Inc (ECL) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported ECL revenue for 2026-06-30 was $8.48B. Net income was $967.5M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the ECL and TOVX stock pages for the full models.
Not investment advice.